CD Markers
Cluster of Differentiation (CD) markers are surface molecules expressed on immune cells that play critical roles in communication, signaling, and immune regulation. Antibodies targeting CD markers are indispensable tools for characterizing immune cell populations, studying their functions, and uncovering mechanisms underlying disease. These insights are essential for advancing new immunological treatments and therapeutic strategies.
Bio X Cell offers a wide selection of antibodies targeting CD markers for both in vivo and in vitro organoid and organ-on-chip models. All Bio X Cell antibodies are ultrapure (≥95% purity), feature endotoxin levels as low as ≤0.5 EU/mg, and are free from preservatives, stabilizers, and carrier proteins.
| Key CD Marker Targets | Description |
|---|---|
| CD3 Antibodies | CD3 is a core component of the T-cell receptor complex and a critical regulator of T-cell activation. Bio X Cell CD3 antibodies are ideal for studying T-cell biology, immune regulation, and cancer immunotherapy. |
| CD4 Antibodies | CD4 is the defining marker of helper T cells and is central to coordinating immune responses. Bio X Cell CD4 antibodies support T-cell biology, HIV research, and immune modulation. |
| CD8 Antibodies | CD8 identifies cytotoxic T cells, essential for antiviral and antitumor immunity. |
| CD20 Antibodies | CD20 is expressed on B cells and is a well-established target in immunology and oncology. Bio X Cell CD20 antibodies support research in B-cell biology, autoimmune disease, and cancer immunotherapy. |
View More
